Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Insmed Incorporated(INSM) | 343,000 | 3,576,038 | +3,233,038 | 9,306 | 239,595 | 3.06% | +230,289 |
| Summit Therapeutics Inc.(SMMT) | 0 | 23,222,222 | +23,222,222 | 0 | 181,133 | 2.31% | +181,133 |
| Alkermes plc(ALKS) | 0 | 4,181,751 | +4,181,751 | 0 | 100,780 | 1.29% | +100,780 |
| Insmed Incorporated(INSM) | 0 | 0 | 0 | 0 | 90,414 | 1.16% | +90,414 |
| Bicycle Therapeutics plc | 4,942,823 | 9,399,960 | +4,457,137 | 123,076 | 190,255 | 2.43% | +67,179 |
| Insmed Incorporated(INSM) | 0 | 0 | 0 | 0 | 56,192 | 0.72% | +56,192 |
| Kiniksa Pharmaceuticals International, plc(KNSA) | 0 | 2,818,323 | +2,818,323 | 0 | 52,618 | 0.67% | +52,618 |
| Revolution Medicines, Inc.(RVMD) | 7,549,249 | 7,569,090 | +19,841 | 243,312 | 293,756 | 3.75% | +50,444 |
| Madrigal Pharmaceuticals, Inc.(MDGL) | 1,969,798 | 1,974,590 | +4,792 | 526,015 | 553,201 | 7.07% | +27,186 |
| Nurix Therapeutics, Inc.(NRIX) | 3,882,125 | 3,882,125 | 0 | 57,067 | 81,020 | 1.04% | +23,953 |
| Alumis Inc. | 0 | 1,562,500 | +1,562,500 | 0 | 20,781 | 0.27% | +20,781 |
| Merus N.V. | 0 | 300,000 | +300,000 | 0 | 17,751 | 0.23% | +17,751 |
| Dyne Therapeutics, Inc.(DYN) | 285,000 | 672,096 | +387,096 | 8,091 | 23,718 | 0.30% | +15,627 |
| Stoke Therapeutics, Inc.(STOK) | 3,368,443 | 4,368,443 | +1,000,000 | 45,474 | 59,018 | 0.75% | +13,544 |
| Replimune Group, Inc.(REPL) | 9,545,336 | 10,045,336 | +500,000 | 77,985 | 90,408 | 1.16% | +12,423 |
| Denali Therapeutics Inc.(DNLI) | 3,731,695 | 3,731,695 | 0 | 76,574 | 86,650 | 1.11% | +10,076 |
| Immatics N.V.(IMTX) | 6,443,398 | 6,443,398 | 0 | 67,720 | 74,872 | 0.96% | +7,152 |
| DBV Technologies S.A. | 0 | 7,307,131 | +7,307,131 | 0 | 5,853 | 0.07% | +5,853 |
| Contineum Therapeutics, Inc. | 0 | 312,500 | +312,500 | 0 | 5,503 | 0.07% | +5,503 |
| CRISPR Therapeutics AG(CRSP) | 0 | 100,000 | +100,000 | 0 | 5,401 | 0.07% | +5,401 |
| Centessa Pharmaceuticals plc | 0 | 549,212 | +549,212 | 0 | 4,959 | 0.06% | +4,959 |
| HOOKIPA Pharma Inc. | 0 | 8,128,151 | +8,128,151 | 0 | 4,810 | 0.06% | +4,810 |
| Crinetics Pharmaceuticals, Inc.(CRNX) | 0 | 103,927 | +103,927 | 0 | 4,655 | 0.06% | +4,655 |
| Alector, Inc. | 0 | 927,264 | +927,264 | 0 | 4,210 | 0.05% | +4,210 |
| KALA BIO, Inc. | 266,613 | 891,335 | +624,722 | 2,125 | 6,320 | 0.08% | +4,195 |
| Skye Bioscience, Inc. | 0 | 500,000 | +500,000 | 0 | 4,005 | 0.05% | +4,005 |
| Arcturus Therapeutics Holdings Inc. | 0 | 151,329 | +151,329 | 0 | 3,685 | 0.05% | +3,685 |
| Generation Bio Co. | 371,219 | 1,206,957 | +835,738 | 1,511 | 3,404 | 0.04% | +1,893 |
| Mirum Pharmaceuticals, Inc.(MIRM) | 190,476 | 190,476 | 0 | 4,785 | 6,512 | 0.08% | +1,728 |
| Neumora Therapeutics, Inc. | 633,851 | 1,034,600 | +400,749 | 8,715 | 10,170 | 0.13% | +1,455 |
| Krystal Biotech, Inc.(KRYS) | 169,934 | 169,934 | 0 | 30,236 | 31,207 | 0.40% | +970 |
| Enliven Therapeutics, Inc. | 114,833 | 114,833 | 0 | 2,020 | 2,684 | 0.03% | +664 |
| Tango Therapeutics, Inc.(TNGX) | 750,000 | 750,000 | 0 | 5,955 | 6,435 | 0.08% | +480 |
| Entrada Therapeutics, Inc. | 4,865,819 | 4,865,819 | 0 | 68,949 | 69,338 | 0.89% | +389 |
| Vaxcyte, Inc.(PCVX) | 48,885 | 48,885 | 0 | 3,339 | 3,691 | 0.05% | +352 |
| Protara Therapeutics, Inc. | 199,671 | 536,832 | +337,161 | 801 | 1,117 | 0.01% | +316 |
| Pfizer Inc.(PFE) | 35,000 | 35,000 | 0 | 971 | 979 | 0.01% | +8 |
| Tyra Biosciences, Inc.(TYRA) | 10,607 | 10,607 | 0 | 174 | 170 | 0.00% | -4 |
| Surrozen, Inc. | 833,333 | 833,333 | 0 | 25 | 14 | 0.00% | -11 |
| PMV Pharmaceuticals, Inc. | 322,024 | 322,024 | 0 | 547 | 522 | 0.01% | -26 |
| Foghorn Therapeutics Inc. | 45,027 | 45,027 | 0 | 302 | 259 | 0.00% | -43 |
| Talis Biomedical Corporation | 508,323 | 508,323 | 0 | 4,448 | 4,403 | 0.06% | -45 |
| Acrivon Therapeutics, Inc. | 52,885 | 52,885 | 0 | 378 | 307 | 0.00% | -71 |
| Perspective Therapeutics, Inc. | 149,787 | 0 | -149,787 | 178 | 0 | — | -178 |
| Cabaletta Bio, Inc. | 13,331 | 0 | -13,331 | 227 | 0 | — | -227 |
| Athira Pharma, Inc. | 3,153,807 | 3,153,807 | 0 | 8,641 | 8,358 | 0.11% | -284 |
| NewAmsterdam Pharma Company N.V. ORDINARY SHARES | 96,827 | 96,827 | 0 | 2,290 | 1,860 | 0.02% | -430 |
| vTv Therapeutics, Inc. | 97,314 | 97,314 | 0 | 2,290 | 1,719 | 0.02% | -571 |
| Achilles Therapeutics plc | 1,208,775 | 1,108,767 | -100,008 | 1,511 | 904 | 0.01% | -607 |
| Leap Therapeutics, Inc. | 1,172,175 | 1,172,175 | 0 | 3,118 | 2,297 | 0.03% | -821 |
| Design Therapeutics, Inc.(DSGN) | 1,662,120 | 1,695,294 | +33,174 | 6,698 | 5,679 | 0.07% | -1,019 |
| Mural Oncology plc | 222,503 | 0 | -222,503 | 1,088 | 0 | — | -1,088 |
| Celldex Therapeutics, Inc.(CLDX) | 247,644 | 247,644 | 0 | 10,394 | 9,165 | 0.12% | -1,228 |
| Century Therapeutics, Inc. | 797,460 | 797,460 | 0 | 3,333 | 2,034 | 0.03% | -1,300 |
| Aligos Therapeutics, Inc. | 2,076,400 | 2,076,400 | 0 | 2,035 | 727 | 0.01% | -1,308 |
| Edgewise Therapeutics, Inc.(EWTX) | 5,840,059 | 5,840,059 | 0 | 106,523 | 105,179 | 1.34% | -1,343 |
| Immunovant, Inc.(IMVT) | 425,009 | 464,718 | +39,709 | 13,732 | 12,269 | 0.16% | -1,463 |
| Compass Therapeutics, Inc. | 1,557,630 | 1,557,630 | 0 | 3,084 | 1,558 | 0.02% | -1,526 |
| Xencor, Inc.(XNCR) | 545,431 | 545,431 | 0 | 12,070 | 10,325 | 0.13% | -1,745 |
| Prime Medicine, Inc. | 1,028,466 | 1,028,466 | 0 | 7,199 | 5,286 | 0.07% | -1,913 |
| Relay Therapeutics, Inc.(RLAY) | 1,160,117 | 1,160,117 | 0 | 9,629 | 7,564 | 0.10% | -2,065 |
| Taysha Gene Therapies, Inc.(TSHA) | 4,004,756 | 4,004,756 | 0 | 11,494 | 8,971 | 0.11% | -2,523 |
| Cerus Corporation | 19,477,339 | 19,477,339 | 0 | 36,812 | 34,280 | 0.44% | -2,532 |
| Praxis Precision Medicines, Inc.(PRAX) | 131,533 | 131,533 | 0 | 8,026 | 5,440 | 0.07% | -2,586 |
| Mersana Therapeutics, Inc. | 1,086,115 | 1,086,115 | 0 | 4,866 | 2,183 | 0.03% | -2,683 |
| Sagimet Biosciences Inc. | 1,381,898 | 1,381,898 | 0 | 7,490 | 4,726 | 0.06% | -2,764 |
| Celcuity Inc.(CELC) | 1,552,478 | 1,874,978 | +322,500 | 33,534 | 30,712 | 0.39% | -2,821 |
| 4D Molecular Therapeutics, Inc. | 100,000 | 0 | -100,000 | 3,186 | 0 | — | -3,186 |
| Alpine Immune Sciences, Inc. | 81,578 | 0 | -81,578 | 3,234 | 0 | — | -3,234 |
| Fate Therapeutics, Inc. | 1,818,181 | 2,997,772 | +1,179,591 | 13,345 | 9,833 | 0.13% | -3,513 |
| 2seventy bio, Inc. | 2,497,526 | 2,497,526 | 0 | 13,362 | 9,615 | 0.12% | -3,746 |
| Xenon Pharmaceuticals Inc.(XENE) | 993,679 | 993,679 | 0 | 42,778 | 38,744 | 0.50% | -4,034 |
| Opthea Limited | 2,177,826 | 2,173,622 | -4,204 | 8,951 | 4,195 | 0.05% | -4,756 |
| Sage Therapeutics, Inc. | 407,217 | 171,026 | -236,191 | 7,631 | 1,857 | 0.02% | -5,774 |
| HOOKIPA Pharma Inc. | 8,128,151 | 0 | -8,128,151 | 5,787 | 0 | — | -5,787 |
| TScan Therapeutics, Inc. | 2,784,792 | 2,784,792 | 0 | 22,111 | 16,291 | 0.21% | -5,820 |
| Neurogene Inc. | 456,015 | 456,015 | 0 | 23,211 | 16,594 | 0.21% | -6,617 |
| Ultragenyx Pharmaceutical Inc.(RARE) | 1,466,547 | 1,466,547 | 0 | 68,473 | 60,275 | 0.77% | -8,198 |
| IDEAYA Biosciences, Inc.(IDYA) | 1,062,123 | 1,062,123 | 0 | 46,606 | 37,291 | 0.48% | -9,315 |
| Prelude Therapeutics Inc. | 10,123,824 | 10,123,824 | 0 | 47,987 | 38,572 | 0.49% | -9,415 |
| Sana Biotechnology, Inc.(SANA) | 2,380,949 | 2,380,949 | 0 | 23,809 | 13,000 | 0.17% | -10,810 |
| DBV Technologies S.A. | 14,614,264 | 0 | -14,614,264 | 10,948 | 0 | — | -10,948 |
| IGM Biosciences, Inc. | 4,088,322 | 4,090,316 | +1,994 | 39,452 | 28,100 | 0.36% | -11,352 |
| argenx SE(ARGX) | 151,215 | 111,904 | -39,311 | 59,536 | 48,123 | 0.61% | -11,413 |
| Verve Therapeutics, Inc. | 1,691,530 | 1,691,530 | 0 | 22,464 | 8,255 | 0.11% | -14,209 |
| Rhythm Pharmaceuticals, Inc.(RYTM) | 6,398,365 | 6,398,365 | 0 | 277,241 | 262,717 | 3.36% | -14,524 |
| Adaptimmune Therapeutics plc | 10,787,022 | 2,343,695 | -8,443,327 | 17,043 | 2,285 | 0.03% | -14,759 |
| Monte Rosa Therapeutics, Inc.(GLUE) | 4,916,095 | 4,916,095 | 0 | 34,658 | 18,386 | 0.23% | -16,272 |
| Sera Prognostics, Inc. | 5,434,399 | 5,434,399 | 0 | 49,453 | 32,172 | 0.41% | -17,281 |
| Biomea Fusion, Inc. | 2,108,949 | 2,108,949 | 0 | 31,529 | 9,490 | 0.12% | -22,039 |
| Cerevel Therapeutics Holdings, Inc. | 1,600,000 | 683,588 | -916,412 | 67,632 | 27,952 | 0.36% | -39,680 |
| Akero Therapeutics, Inc. | 2,713,205 | 1,097,082 | -1,616,123 | 68,536 | 25,738 | 0.33% | -42,798 |
| AbCellera Biologics Inc.(ABCL) | 27,525,640 | 27,525,640 | 0 | 124,691 | 81,476 | 1.04% | -43,215 |
| Immunocore Holdings plc(IMCR) | 1,515,318 | 1,515,318 | 0 | 98,496 | 51,354 | 0.66% | -47,142 |
| Roivant Sciences Ltd.(ROIV) | 7,413,834 | 2,798,716 | -4,615,118 | 78,142 | 29,582 | 0.38% | -48,559 |
| Aerovate Therapeutics, Inc. | 1,680,517 | 628,939 | -1,051,578 | 49,693 | 1,044 | 0.01% | -48,649 |
| Kodiak Sciences Inc.(KOD) | 17,310,490 | 17,310,490 | 0 | 91,053 | 40,680 | 0.52% | -50,374 |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 10,126,176 | 75,778 | -10,050,398 | 51,441 | 468 | 0.01% | -50,973 |
| Kiniksa Pharmaceuticals, Ltd. | 2,809,577 | 0 | -2,809,577 | 55,433 | 0 | — | -55,433 |
| Kymera Therapeutics, Inc.(KYMR) | 5,995,928 | 5,995,928 | 0 | 241,036 | 178,978 | 2.29% | -62,058 |